Probity Advisors, Inc. Bristol Myers Squibb CO Transaction History

Probity Advisors, Inc.

$515 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $38,348 - $45,410	-560 Reduced 13.02%	3,740 $269,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $77 - $46,027	-599 Reduced 12.23%	4,300 $306,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $29,338 - $32,311	-404 Reduced 7.62%	4,899 $377,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $44,757 - $53,668	-728 Reduced 12.07%	5,303 $387,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $38,130 - $44,451	711 Added 13.36%	6,031 $376,000
Q3 2021 Oct 08, 2021	BUY	$59.17 - $69.31 $18,756 - $21,971	317 Added 6.34%	5,320 $315,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $13,372 - $14,562	-216 Reduced 4.14%	5,003 $334,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $123,961 - $139,419	-2,089 Reduced 28.59%	5,219 $329,000
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $20,502 - $22,719	357 Added 5.14%	7,308 $441,000
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $2,302 - $2,691	42 Added 0.61%	6,951 $409,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $9,280 - $13,486	-200 Reduced 2.81%	6,909 $385,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $110,230 - $143,785	2,240 Added 46.01%	7,109 $456,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $7,313 - $8,671	171 Added 3.64%	4,869 $247,000
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $35,517 - $39,274	-796 Reduced 14.49%	4,698 $213,000
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $31,854 - $37,982	706 Added 14.75%	5,494 $262,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $4,924 - $6,386	-101 Reduced 2.07%	4,788 $249,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $13,080 - $14,753	-237 Reduced 4.62%	4,889 $304,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $15,815 - $19,712	313 Added 6.5%	5,126 $284,000
Q1 2018 Apr 16, 2018	BUY	$59.92 - $68.98 $5,452 - $6,277	91 Added 1.93%	4,813 $304,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $19,120 - $20,846	-319 Reduced 6.33%	4,722 $289,000
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $278,414 - $321,313	5,041	5,041 $321,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account